Human noroviruses are the primary causative agents of acute gastroenteritis and a pressing public health burden worldwide. There are currently no vaccines or small molecule therapeutics available for the treatment or prophylaxis of norovirus infections. Norovirus 3CL protease plays a vital role in viral replication by generating structural and nonstructural proteins via the cleavage of the viral polyprotein. Thus, molecules that inhibit the viral protease may have potential therapeutic value. We describe herein the structure-based design, synthesis, and in vitro and cell-based evaluation of the first class of oxadiazole-based, permeable macrocyclic inhibitors of norovirus 3CL protease.
Humannoroviruses are the primary causative agents of acute n class="Disease">gastroenteritis and a pressing public health burden worldwide. There are currently no vaccines or small molecule therapeutics available for the treatment or prophylaxis of norovirus infections. Norovirus 3CL protease plays a vital role in viral replication by generating structural and nonstructural proteins via the cleavage of the viral polyprotein. Thus, molecules that inhibit the viral protease may have potential therapeutic value. We describe herein the structure-based design, synthesis, and in vitro and cell-based evaluation of the first class of oxadiazole-based, permeable macrocyclic inhibitors of norovirus 3CL protease.
Authors: Anushka C Galasiti Kankanamalage; Yunjeong Kim; Pathum M Weerawarna; Roxanne Adeline Z Uy; Vishnu C Damalanka; Sivakoteswara Rao Mandadapu; Kevin R Alliston; Nurjahan Mehzabeen; Kevin P Battaile; Scott Lovell; Kyeong-Ok Chang; William C Groutas Journal: J Med Chem Date: 2015-03-19 Impact factor: 7.446
Authors: Yunjeong Kim; Scott Lovell; Kok-Chuan Tiew; Sivakoteswara Rao Mandadapu; Kevin R Alliston; Kevin P Battaile; William C Groutas; Kyeong-Ok Chang Journal: J Virol Date: 2012-08-22 Impact factor: 5.103
Authors: Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson Journal: Acta Crystallogr D Biol Crystallogr Date: 2009-12-21
Authors: Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read Journal: J Appl Crystallogr Date: 2007-07-13 Impact factor: 3.304
Authors: Anushka C Galasiti Kankanamalage; Pathum M Weerawarna; Athri D Rathnayake; Yunjeong Kim; Nurjahan Mehzabeen; Kevin P Battaile; Scott Lovell; Kyeong-Ok Chang; William C Groutas Journal: Proteins Date: 2019-04-01
Authors: Vishnu C Damalanka; Yunjeong Kim; Anushka C Galasiti Kankanamalage; Athri D Rathnayake; Nurjahan Mehzabeen; Kevin P Battaile; Scott Lovell; Harry Nhat Nguyen; Gerald H Lushington; Kyeong-Ok Chang; William C Groutas Journal: Eur J Med Chem Date: 2017-12-06 Impact factor: 6.514
Authors: Vishnu C Damalanka; Yunjeong Kim; Anushka C Galasiti Kankanamalage; Gerald H Lushington; Nurjahan Mehzabeen; Kevin P Battaile; Scott Lovell; Kyeong-Ok Chang; William C Groutas Journal: Eur J Med Chem Date: 2016-12-21 Impact factor: 6.514
Authors: Anushka C Galasiti Kankanamalage; Yunjeong Kim; Athri D Rathnayake; Vishnu C Damalanka; Pathum M Weerawarna; Sean T Doyle; Amer F Alsoudi; D M Padmasankha Dissanayake; Gerald H Lushington; Nurjahan Mehzabeen; Kevin P Battaile; Scott Lovell; Kyeong-Ok Chang; William C Groutas Journal: Eur J Med Chem Date: 2016-11-14 Impact factor: 6.514
Authors: Vishnu C Damalanka; Jorine J L P Voss; Matthew W Mahoney; Tina Primeau; Shunqiang Li; Lidija Klampfer; James W Janetka Journal: J Med Chem Date: 2021-12-13 Impact factor: 8.039